FI20075159A0 - Fuusiopolypeptidi konservoitujen yhdistelmä- tai komposiittiepitooppien havannointiin ei-konservoituneista proteiineista - Google Patents

Fuusiopolypeptidi konservoitujen yhdistelmä- tai komposiittiepitooppien havannointiin ei-konservoituneista proteiineista

Info

Publication number
FI20075159A0
FI20075159A0 FI20075159A FI20075159A FI20075159A0 FI 20075159 A0 FI20075159 A0 FI 20075159A0 FI 20075159 A FI20075159 A FI 20075159A FI 20075159 A FI20075159 A FI 20075159A FI 20075159 A0 FI20075159 A0 FI 20075159A0
Authority
FI
Finland
Prior art keywords
conserved
recombinant
detection
fusion polypeptide
proteins
Prior art date
Application number
FI20075159A
Other languages
English (en)
Swedish (sv)
Other versions
FI20075159A (fi
FI120349B (fi
Inventor
Kalle Saksela
Original Assignee
Next Biomed Technologies Nbt O
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Next Biomed Technologies Nbt O filed Critical Next Biomed Technologies Nbt O
Publication of FI20075159A0 publication Critical patent/FI20075159A0/fi
Priority to FI20075159A priority Critical patent/FI120349B/fi
Priority to EP08718564A priority patent/EP2129689A4/en
Priority to JP2009552239A priority patent/JP2010520266A/ja
Priority to MX2009009503A priority patent/MX2009009503A/es
Priority to US12/530,019 priority patent/US8735328B2/en
Priority to CN200880015324A priority patent/CN101679514A/zh
Priority to AU2008223755A priority patent/AU2008223755A1/en
Priority to CA002680123A priority patent/CA2680123A1/en
Priority to PCT/FI2008/050111 priority patent/WO2008107523A2/en
Publication of FI20075159A publication Critical patent/FI20075159A/fi
Application granted granted Critical
Publication of FI120349B publication Critical patent/FI120349B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1054—Lentiviridae, e.g. HIV, FIV, SIV gag-pol, e.g. p17, p24
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1037—Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1058—Directional evolution of libraries, e.g. evolution of libraries is achieved by mutagenesis and screening or selection of mixed population of organisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5306—Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/15—Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
    • G01N2333/155—Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV
    • G01N2333/16—HIV-1, HIV-2
    • G01N2333/161—HIV-1, HIV-2 gag-pol, e.g. p55, p24/25, p17/18, p.7, p6, p66/68, p51/52, p31/34, p32, p40

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • AIDS & HIV (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Ecology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FI20075159A 2007-03-07 2007-03-07 Menetelmä fuusiopolypeptidin valmistamiseksi FI120349B (fi)

Priority Applications (9)

Application Number Priority Date Filing Date Title
FI20075159A FI120349B (fi) 2007-03-07 2007-03-07 Menetelmä fuusiopolypeptidin valmistamiseksi
US12/530,019 US8735328B2 (en) 2007-03-07 2008-03-07 Fusion polypeptide for detection of conserved combinatorial or composite epitopes in non-conserved proteins
JP2009552239A JP2010520266A (ja) 2007-03-07 2008-03-07 非保存性タンパク質内の、保存性のコンビナトリアルエピトープまたは複合エピトープを検出するための融合ポリペプチド
MX2009009503A MX2009009503A (es) 2007-03-07 2008-03-07 Un polipeptido de fusion para deteccion de epitopos combinatorios conservados o compuestos en proteinas no conservadas.
EP08718564A EP2129689A4 (en) 2007-03-07 2008-03-07 FUSION POLYPEPTIDE FOR DETECTING COMBINATION OR COMPOSITE EPITOPES PRESERVED IN NON-PRESERVED PROTEINS
CN200880015324A CN101679514A (zh) 2007-03-07 2008-03-07 用于检测非保守蛋白质中保守的组合或复合表位的融合多肽
AU2008223755A AU2008223755A1 (en) 2007-03-07 2008-03-07 A fusion polypeptide for detection of conserved combinatorial or composite epitopes in non-conserved proteins
CA002680123A CA2680123A1 (en) 2007-03-07 2008-03-07 A fusion polypeptide for detection of conserved combinatorial or composite epitopes in non-conserved proteins
PCT/FI2008/050111 WO2008107523A2 (en) 2007-03-07 2008-03-07 A fusion polypeptide for detection of conserved combinatorial or composite epitopes in non-conserved proteins

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20075159 2007-03-07
FI20075159A FI120349B (fi) 2007-03-07 2007-03-07 Menetelmä fuusiopolypeptidin valmistamiseksi

Publications (3)

Publication Number Publication Date
FI20075159A0 true FI20075159A0 (fi) 2007-03-07
FI20075159A FI20075159A (fi) 2008-09-08
FI120349B FI120349B (fi) 2009-09-30

Family

ID=37930071

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20075159A FI120349B (fi) 2007-03-07 2007-03-07 Menetelmä fuusiopolypeptidin valmistamiseksi

Country Status (9)

Country Link
US (1) US8735328B2 (fi)
EP (1) EP2129689A4 (fi)
JP (1) JP2010520266A (fi)
CN (1) CN101679514A (fi)
AU (1) AU2008223755A1 (fi)
CA (1) CA2680123A1 (fi)
FI (1) FI120349B (fi)
MX (1) MX2009009503A (fi)
WO (1) WO2008107523A2 (fi)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7176724B2 (ja) 2018-07-20 2022-11-22 国立大学法人滋賀医科大学 ヒト末梢性コリン作動性神経検出用抗体

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO314588B1 (no) 2000-09-04 2003-04-14 Bionor Immuno As HIV-peptider, antigener, vaksinesammensetning, immunoassay- testsett og en fremgangsmåte for å påvise antistoffer indusert av HIV
US6610472B1 (en) 2000-10-31 2003-08-26 Genetastix Corporation Assembly and screening of highly complex and fully human antibody repertoire in yeast
US6833441B2 (en) 2001-08-01 2004-12-21 Abmaxis, Inc. Compositions and methods for generating chimeric heteromultimers
GB0305702D0 (en) * 2003-03-12 2003-04-16 Univ Birmingham Bispecific antibodies

Also Published As

Publication number Publication date
US8735328B2 (en) 2014-05-27
WO2008107523A8 (en) 2009-07-30
FI20075159A (fi) 2008-09-08
US20100190655A1 (en) 2010-07-29
WO2008107523A2 (en) 2008-09-12
AU2008223755A1 (en) 2008-09-12
EP2129689A4 (en) 2011-11-02
CN101679514A (zh) 2010-03-24
MX2009009503A (es) 2010-02-17
JP2010520266A (ja) 2010-06-10
EP2129689A1 (en) 2009-12-09
CA2680123A1 (en) 2008-09-12
FI120349B (fi) 2009-09-30

Similar Documents

Publication Publication Date Title
IL275846A (en) ACTRIIB–FC truncated fusion proteins
BRPI0907363A2 (pt) Métodos e composições relativos a peptídeos e proteínas com elementos de c-terminal
IL210175A0 (en) Fn14/trail fusion proteins
HK1219490A1 (zh) 免疫球蛋白融合蛋白
IL218296A0 (en) Obpgplys/endolysin polypeptides, fusion proteins and compositions compriisng the same and uses thereof
BRPI0716744A2 (pt) proteínas de fusão de albumina
DK2035447T3 (da) Polypeptid
EP2242505A4 (en) GLYCOCONJUGATION OF POLYPEPTIDES USING OLIGOSACCHARYLTRANSFERASES
WO2013184939A3 (en) Fusion polypeptides comprising an active protein linked to a mucin-domain polypeptide
IL204839A0 (en) Albumin fusion proteins
BRPI1009221A2 (pt) proteínas de fusão transcriptase reversa estabilizadas.
BRPI0819210A2 (pt) Anticorpos de proteína g anti-rsv
EP2001517A4 (en) REGULATED EXPRESSION OF RECOMBINANT PROTEINS FROM ADENO-ASSOCIATED VIRAL VECTORS
IL236236A (en) Antibodies to the fam26f polypeptide
BRPI0814127A2 (pt) Polipeptídeos imunegênicos e anticorpos monoclonais
BRPI1008035A2 (pt) anticorpos contendo peptídeos terapêuticos miméticos de tpo/epo
DK2607486T3 (da) KEX2-kløvningsregioner af rekombinante fusionsproteiner
BRPI0915718A2 (pt) peptídeos de direção crkl
PL2201120T3 (pl) Systemy białek fuzyjnych GCSF odpowiednie do wysokiej ekspresji peptydów
GB2465683B (en) LL-37 Related Fusion Peptides
ATE484749T1 (de) Von anti-trichinella-antikörpern erkannte polypeptide und ihre verwendung
EP2161284A4 (en) CITRULLINED FIBRIN-FILAGRIN RECOMBINANT POLYPEPTIDE CAPABLE OF DETECTING ANTIBODIES GENERATED IN RHEUMATOID ARTHRITIS
DK2547694T5 (da) Hidtil ukendt signalpeptid og anvendelse deraf til fremstilling af rekombinante proteiner
DK2248533T3 (da) Polypeptid afledt af enterococcus samt dets anvendelse til vaccination
WO2008101671A3 (en) Il-4 fc fusion proteins

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 120349

Country of ref document: FI

MM Patent lapsed